273 related articles for article (PubMed ID: 26402657)
1. The future of patient-derived tumor xenografts in cancer treatment.
Sia D; Moeini A; Labgaa I; Villanueva A
Pharmacogenomics; 2015; 16(14):1671-83. PubMed ID: 26402657
[TBL] [Abstract][Full Text] [Related]
2. Ovarian and cervical cancer patient derived xenografts: The past, present, and future.
Boone JD; Dobbin ZC; Straughn JM; Buchsbaum DJ
Gynecol Oncol; 2015 Aug; 138(2):486-91. PubMed ID: 26026736
[TBL] [Abstract][Full Text] [Related]
3. Molecular and clinical implementations of ovarian cancer mouse avatar models.
Zayed AA; Mandrekar SJ; Haluska P
Chin Clin Oncol; 2015 Sep; 4(3):30. PubMed ID: 26408297
[TBL] [Abstract][Full Text] [Related]
4. Patient-derived xenograft platform of OSCC: a renewable human bio-bank for preclinical cancer research and a new co-clinical model for treatment optimization.
Sun S; Zhang Z
Front Med; 2016 Mar; 10(1):104-10. PubMed ID: 26926009
[TBL] [Abstract][Full Text] [Related]
5. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
Navone NM; van Weerden WM; Vessella RL; Williams ED; Wang Y; Isaacs JT; Nguyen HM; Culig Z; van der Pluijm G; Rentsch CA; Marques RB; de Ridder CMA; Bubendorf L; Thalmann GN; Brennen WN; Santer FR; Moser PL; Shepherd P; Efstathiou E; Xue H; Lin D; Buijs J; Bosse T; Collins A; Maitland N; Buzza M; Kouspou M; Achtman A; Taylor RA; Risbridger G; Corey E
Prostate; 2018 Dec; 78(16):1262-1282. PubMed ID: 30073676
[TBL] [Abstract][Full Text] [Related]
6. Patient-derived xenografts: a valuable platform for clinical and preclinical research in pancreatic cancer.
Wang Y; Cui J; Wang L
Chin Clin Oncol; 2019 Apr; 8(2):17. PubMed ID: 30943729
[TBL] [Abstract][Full Text] [Related]
7. Of Mice and Melanoma: PDX System for Modeling Personalized Medicine.
Hartsough EJ; Aplin AE
Clin Cancer Res; 2016 Apr; 22(7):1550-2. PubMed ID: 26842234
[TBL] [Abstract][Full Text] [Related]
8. Patient-derived xenografts: A platform for accelerating translational research in prostate cancer.
Davies AH; Wang Y; Zoubeidi A
Mol Cell Endocrinol; 2018 Feb; 462(Pt A):17-24. PubMed ID: 28315377
[TBL] [Abstract][Full Text] [Related]
9. Patient-derived xenograft models of breast cancer and their predictive power.
Whittle JR; Lewis MT; Lindeman GJ; Visvader JE
Breast Cancer Res; 2015 Feb; 17(1):17. PubMed ID: 25849559
[TBL] [Abstract][Full Text] [Related]
10. Patient-derived xenograft (PDX) models, applications and challenges in cancer research.
Abdolahi S; Ghazvinian Z; Muhammadnejad S; Saleh M; Asadzadeh Aghdaei H; Baghaei K
J Transl Med; 2022 May; 20(1):206. PubMed ID: 35538576
[TBL] [Abstract][Full Text] [Related]
11. Establishment of patient-derived cancer xenografts in immunodeficient NOG mice.
Chijiwa T; Kawai K; Noguchi A; Sato H; Hayashi A; Cho H; Shiozawa M; Kishida T; Morinaga S; Yokose T; Katayama M; Takenaka N; Suemizu H; Yamada R; Nakamura Y; Ohtsu T; Takano Y; Imai K; Miyagi Y; Nakamura M
Int J Oncol; 2015 Jul; 47(1):61-70. PubMed ID: 25963555
[TBL] [Abstract][Full Text] [Related]
12. Patient-derived xenografts for childhood solid tumors: a valuable tool to test new drugs and personalize treatments.
Zarzosa P; Navarro N; Giralt I; Molist C; Almazán-Moga A; Vidal I; Soriano A; Segura MF; Hladun R; Villanueva A; Gallego S; Roma J
Clin Transl Oncol; 2017 Jan; 19(1):44-50. PubMed ID: 27718156
[TBL] [Abstract][Full Text] [Related]
13. Prioritizing therapeutic targets using patient-derived xenograft models.
Lodhia KA; Hadley AM; Haluska P; Scott CL
Biochim Biophys Acta; 2015 Apr; 1855(2):223-34. PubMed ID: 25783201
[TBL] [Abstract][Full Text] [Related]
14. Patient-Derived Xenograft: An Adjuvant Technology for the Treatment of Metastatic Disease.
Bousquet G; Janin A
Pathobiology; 2016; 83(4):170-6. PubMed ID: 27010922
[TBL] [Abstract][Full Text] [Related]
15. Choosing wisely - Preclinical test models in the era of precision medicine.
Klinghammer K; Walther W; Hoffmann J
Cancer Treat Rev; 2017 Apr; 55():36-45. PubMed ID: 28314175
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer patient-derived xenografted tumors maintain characteristic features of the original tumors.
Cho YB; Hong HK; Choi YL; Oh E; Joo KM; Jin J; Nam DH; Ko YH; Lee WY
J Surg Res; 2014 Apr; 187(2):502-9. PubMed ID: 24332554
[TBL] [Abstract][Full Text] [Related]
17. Advances in patient-derived tumor xenografts: from target identification to predicting clinical response rates in oncology.
Rosfjord E; Lucas J; Li G; Gerber HP
Biochem Pharmacol; 2014 Sep; 91(2):135-43. PubMed ID: 24950467
[TBL] [Abstract][Full Text] [Related]
18. [Application and development of patient-derived tumor xenograft model in translational medicine of tumor].
Wang Z; Zhu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):596-600. PubMed ID: 28534338
[TBL] [Abstract][Full Text] [Related]
19. Patient-derived xenograft models: an emerging platform for translational cancer research.
Hidalgo M; Amant F; Biankin AV; Budinská E; Byrne AT; Caldas C; Clarke RB; de Jong S; Jonkers J; Mælandsmo GM; Roman-Roman S; Seoane J; Trusolino L; Villanueva A
Cancer Discov; 2014 Sep; 4(9):998-1013. PubMed ID: 25185190
[TBL] [Abstract][Full Text] [Related]
20. The Generation and Application of Patient-Derived Xenograft Model for Cancer Research.
Jung J; Seol HS; Chang S
Cancer Res Treat; 2018 Jan; 50(1):1-10. PubMed ID: 28903551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
